Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 1534 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3406    
    Printed117    
    Emailed7    
    PDF Downloaded586    
    Comments [Add]    

Recommend this journal

 
INVITED ARTICLE
Year : 2009  |  Volume : 51  |  Issue : 5  |  Page : 44-51

Mild cognitive impairment: The dilemma


Department of Psychiatry, TN Medical College and BYL Nair Hospital, Mumbai - 400008, India

Correspondence Address:
Charles Pinto
Department of Topiwala National Medical College and BYL Nair Charitable Hospital, Mumbai - 400008
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21416016

Rights and PermissionsRights and Permissions

Memory complaints are ubiquitous in our aging population. Many older adults fear that today's forgetfulness will usher in tomorrow's dementia. Mild cognitive impairment (MCI) is considered by many as an intermediary stage for dementia. Though the nomenclature has been varied and extensive, the criteria by the American Academy of Neurology and the EADC have been helpful. Prevalence rates varying from 3% to as high as 59% with a conversion rate to dementia varying from 8 to 15% only increases the need for diagnostic tests and markers which are in the form of neuropsychological tests, neuroimaging and other biological markers. Medications indicated for treatment of mild to severe Alzheimer's Disease (AD) are offered to persons with MCI with a varying type of response which does not hold in the long run to newer strategies of exploring disease modifying drugs which hold a better promise. This benefit with management of risk factors like hypertension and diabetes coupled with non-pharmacological approaches like exercise and social networking has thrust upon us the necessity for coordinating our efforts to improve detection and management of MCI.



[FULL TEXT] [PDF]*

        

Print this article         Email this article